CION Cancer Clinics
Why TURBT is both the diagnosis and the treatment | CION Cancer Clinics
A TURBT is both things at once because the same scrape that removes the bladder growth is the sample the laboratory reads. No separate biopsy comes first. The report that follows gives the type, the grade and how deep the cancer had grown, and that decides whether the operation was the whole treatment or only the first step. This page explains both halves. CION Cancer Clinics’ surgical oncologists in Hyderabad can talk this through with you.
On this page
- How can one operation be both a diagnosis and a treatment?
- What does the tissue from a TURBT actually tell the team?
- From the first camera test to the next decision
- The same operation, in its two roles
- When is TURBT not enough as a treatment?
- Three things families tell us, and what is actually true
- Common questions about TURBT as diagnosis and treatment
The short answer
How can one operation be both a diagnosis and a treatment?
Because the same scrape that removes the bladder growth is also the sample the laboratory reads. A TURBT takes the growth away, and the tissue that comes out tells your team what it was, how abnormal the cells are, and how deep it had grown. No separate biopsy, a small tissue sample, is needed first.
Why the bladder is unusual in this way
In most cancers the order is fixed: biopsy first, result, then a planned operation. In the bladder, the growth can be seen directly through a telescope and reached through the urine passage. So the surgeon removes it in full at the first visit rather than taking a small piece and coming back later. What is taken out is the diagnosis.
What that means for you
You will usually go into the operation knowing only that something was seen on a scan or a camera test. You come out with the growth removed and a wait of about a week for the report. That report, not the operation itself, decides what happens next. It may say the TURBT was the whole treatment. It may say it was only the first step.
Nothing on this page can tell you which of those applies to you or your parent. Only the pathology report can.The diagnosis half
What does the tissue from a TURBT actually tell the team?
Four answers come back from the laboratory. Together they place the cancer in a risk group, and the risk group sets the plan.
What kind of cancer it is
Most bladder cancers start in the lining cells, called urothelial cancer on the report. Less common types behave differently and may change the plan, so the type is always stated first.
How abnormal the cells look
This is the grade. Low grade cells look close to normal and tend to grow slowly. High grade cells look very different and are more likely to come back and to grow deeper.
How deep it had grown
This is the stage, meaning how far into the bladder wall the cancer reached. On the lining only, into the layer just beneath it, or into the muscle. This single answer separates two very different treatment paths.
Whether muscle was in the sample
The report says whether the surgeon reached the muscle layer. If no muscle was seen, the depth answer is incomplete and a second TURBT is often arranged to settle it.
Also noted
- Flat red patches, called carcinoma in situ
- Whether more than one growth was found
Not sure whether this applies to you?
Ask an oncologistThe pathway
From the first camera test to the next decision
-
Something is seen
Usually blood in the urine leads to an ultrasound or a CT scan, then a cystoscopy, a camera test done through the urine passage in the clinic. A growth is seen and TURBT is arranged.
-
The TURBT
Under spinal or general anaesthetic, the surgeon removes every growth that can be seen and deliberately scrapes into the muscle beneath. Everything removed goes to the laboratory in labelled pots.
-
The report
About a week later the type, grade, depth and muscle status come back. Your team reads them together with the scan and the operation note.
-
The risk group
Cancers that have not reached the muscle are sorted into low, intermediate and high risk groups. Cancers in the muscle move to a separate pathway altogether.
-
The plan
Low risk usually means check cystoscopies. Intermediate and high risk usually mean medicine washes into the bladder, and often a second TURBT first. Muscle-invasive cancer means a conversation about removing the bladder or treating it with radiotherapy and chemotherapy.
Side by side
The same operation, in its two roles
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Being straight with you
When is TURBT not enough as a treatment?
When the cancer has reached the muscle of the bladder wall, or has spread beyond the bladder, the scrape cannot reach it all. In that situation TURBT has done its diagnostic job well, but treating the cancer needs something bigger.
What the next conversation is about
For muscle-invasive cancer the usual options are removing the bladder, or a combination of TURBT, chemotherapy and radiotherapy that aims to keep it. Both are serious decisions with different trade-offs, and your team will lay them out rather than decide for you. Ask what they would weigh in your case, and bring the family member who will be part of the decision.
What it cannot see
A TURBT only finds what the telescope can see. Cells that have already travelled to lymph nodes, the small glands that drain the bladder, or to other organs do not show up in the bladder at all. That is why a CT scan of the abdomen and chest is usually done alongside, and why a normal TURBT report is read together with it and never on its own.
Who the single-visit approach may not suit
A very large growth, heavy bleeding, or a person who cannot safely have a long anaesthetic may mean the surgeon plans a staged operation, or takes a smaller sample first. That is a judgement made in the room, and it is worth asking at the consent visit whether it is likely.
Commonly believed
Three things families tell us, and what is actually true
In the bladder, the operation is the biopsy. A small pinch would give a poorer answer, because it cannot show depth, and it would still leave the growth behind. Removing it in full at the first visit gives the fuller report and starts treatment on the same day.
What the surgeon sees is size and shape. Grade and depth come only from the microscope, and a small growth can be high grade. Wait for the report before deciding what it means.
Bladder cancer that has not reached the muscle comes back in the bladder more often than almost any other cancer returns. Each return is easier to deal with when it is small, and the only way to find it small is to look on a schedule.
The surgeon sends the growth and the base beneath it to the laboratory in separate pots. The base is what shows whether the cancer reached the muscle, which is why the report can say "muscle present" or "no muscle seen" even when the growth itself was removed cleanly.
Questions we are asked
Common questions about TURBT as diagnosis and treatment
Will the surgeon know on the day whether it is cancer?
Often they will have a strong impression from how the growth looked, and they may tell you that. But the diagnosis, the grade and the depth come only from the laboratory. Treat anything said on the day as a first impression, and wait for the written report before drawing conclusions or telling the wider family.
How long does the pathology report take?
Usually about a week, sometimes longer if extra stains are needed to settle the type or the depth. If the wait is stretching, ask the ward or call the helpline and someone will find out where it is. Waiting is the hardest part, and it is normal to find it so.
If the report is good, is my father finished with treatment?
Finished with surgery, perhaps, but not with care. Even the lowest risk group needs check cystoscopies on a schedule, because this cancer often returns in the bladder. Higher risk groups usually need medicine washes into the bladder as well. The report places him in a group, and the group sets the follow-up.
What does "non-muscle-invasive" mean?
The cancer was found on the lining or in the thin layer just under it, and had not grown into the bladder muscle. This is the group where TURBT, washes and check cystoscopies are the usual treatment and the bladder is kept. It is the more common finding at a first TURBT.
Why does the report mention a second TURBT?
A second look is standard when the first report shows high grade cancer, cancer in the layer under the lining, or a sample without muscle in it. It checks that nothing was left behind and settles the depth. A separate page here explains it in full.
Can the operation itself spread the cancer?
This is a common worry and it is not what happens with a TURBT. The bladder is a closed space, the growth is removed under direct vision and the base is sealed. A single medicine wash is sometimes given straight afterwards to reduce the chance of loose cells settling elsewhere in the bladder lining.
Do we need a CT scan as well?
Usually yes, and often it has already been done. The TURBT reads the bladder; the CT reads the kidneys, the tubes down from them, the lymph nodes and the rest of the abdomen. The two together give the full staging, meaning the full picture of how far the cancer has gone.
Is TURBT covered by Aarogyasri or insurance?
TURBT for a bladder growth is a recognised cancer procedure, so Aarogyasri, CGHS, ECHS, EHS and most cashless insurers usually cover it at an empanelled centre. Cover for the follow-up cystoscopies and washes can differ. Call the helpline with your card details and we will check before you travel.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- Cancer Research UK — Bladder cancer: treatment
- National Cancer Institute — Bladder Cancer Treatment (PDQ), patient version
- NHS — Bladder cancer: treatment
- NICE — Bladder cancer: diagnosis and management (NG2)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Waiting for a TURBT report, or been told you need one?
Send us what you have so far and we will help you reach a surgical oncologist who can explain what the report means and what the next step is. One helpline serves every CION centre.